LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With ...

Retrieved on: 2021-04-23 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With .... View article details on hiswai:

Excerpt

LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 2021.

Article found on: www.citizentribune.com